Viracta Therapeutics, Inc. (VIRX) has 20 open-market insider trades by 4 insiders since 2021. The most active filer is Daniel R. Chevallard, CFO and COO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Ivor Royston | CEOPres | — | 4 | $217K | 2024-11-25 |
| Daniel R. Chevallard | CFO and COO | — | 9 | $63K | 2024-02-27 |
| Lisa Rojkjaer | Chief Medical Officer | — | 6 | $51K | 2023-02-27 |
| Mark Rothera | Pres | — | 1 | $49K | 2023-12-01 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Daniel R. Chevallard | CFO and COO | Sell | $2K | 2024-02-27 |
| Mark Rothera | President | Buy | $49K | 2023-11-30 |
| Daniel R. Chevallard | CFO and COO | Sell | $2K | 2023-11-28 |
| Daniel R. Chevallard | CFO and COO | Sell | $5K | 2023-08-28 |
| Daniel R. Chevallard | CFO and COO | Sell | $5K | 2023-05-25 |
| Lisa Rojkjaer | Chief Medical Officer | Sell | $4K |
Companies that share insiders with VIRX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2023-02-27 |
| Daniel R. Chevallard | CFO and COO | Sell | $6K | 2023-02-27 |
| Daniel R. Chevallard | CFO and COO | Sell | $10K | 2022-11-28 |
| Lisa Rojkjaer | Chief Medical Officer | Sell | $6K | 2022-11-28 |
| Lisa Rojkjaer | Chief Medical Officer | Sell | $9K | 2022-08-26 |
| Daniel R. Chevallard | CFO and COO | Sell | $15K | 2022-08-26 |
| Ivor Royston | CEO & President | Sell | $107K | 2022-08-26 |
| Daniel R. Chevallard | CFO and COO | Sell | $7K | 2022-05-26 |
| Ivor Royston | President | Sell | $25K | 2022-05-26 |
| Lisa Rojkjaer | Chief Medical Officer | Sell | $4K | 2022-05-26 |